Achiko AG (Achiko AG) Total Assets : $2.35 Mil (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Total Assets?

Achiko AG's Total Assets for the quarter that ended in Jun. 2022 was $2.35 Mil.

Total Assets is connected with ROA %. Achiko AG's annualized ROA % for the quarter that ended in Jun. 2022 was -234.26%. Total Assets is also linked to Revenue through Asset Turnover. Achiko AG's Asset Turnover for the quarter that ended in Jun. 2022 was 0.00.

Achiko AG Total Assets Historical Data

The historical data trend for Achiko AG's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Total Assets Chart

Achiko AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Total Assets

3.37

3.66

1.77

1.91

Achiko AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Total Assets	Get a 7-Day Free Trial			3.11	1.77	1.61	1.91	2.35

Achiko AG Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Achiko AG's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets	=	Total Equity (A: Dec. 2021 )	+	Total Liabilities (A: Dec. 2021 )
	=	-4.585	+	6.499
	=	1.91

Achiko AG's Total Assets for the quarter that ended in Jun. 2022 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2022 )	+	Total Liabilities (Q: Jun. 2022 )
	=	-6.908	+	9.256
	=	2.35

Achiko AG (OTCPK:ACHKF) Total Assets Explanation

Total Assets is connected with ROA %.

Achiko AG's annualized ROA % for the quarter that ended in Jun. 2022 is

ROA %	=	Net Income (Q: Jun. 2022 )	/	( (Total Assets (Q: Dec. 2021 )	+	Total Assets (Q: Jun. 2022 ))	/ count )
	=	-4.992	/	( (1.914	+	2.348)	/ 2 )
	=	-4.992	/	2.131
	=	-234.26 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Achiko AG's Asset Turnover for the quarter that ended in Jun. 2022 is

	Asset Turnover
=	Revenue (Q: Jun. 2022 )	/	( (Total Assets (Q: Dec. 2021 )	+	Total Assets (Q: Jun. 2022 ))	/ count )
=	0	/	( (1.914	+	2.348)	/ 2 )
=	0	/	2.131
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Achiko AG Total Assets Related Terms

Thank you for viewing the detailed overview of Achiko AG's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Achiko AG (Achiko AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tessinerplatz 7, Zurich, CHE, CH-8002

Website

https://www.achiko.com

Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.